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Viruses possess elaborate defensive mechanisms to evade host innate immune responses. In this issue of
Cell Host & Microbe, Stavrou et al. (2015) reveal how the murine leukemia virus uses a sugar-protein shield
to protect from inevitable destruction by cellular innate immune factors including the APOBEC3 DNA
mutating enzyme.Mammalian cells have mechanisms to
protect from potentially harmful foreign
nucleic acids, including viral RNA and
DNA. Deficiencies in these mechanisms
can predispose to viral infections and
precipitate autoimmune diseases. For
instance, defects in a DNA exonuclease
(TREX1), a dNTP hydrolase (SAMHD1), a
double-stranded RNA editing enzyme
(ADAR1), an RNA/DNA hybrid endonu-
clease (RNaseH2), and a cytosolic RNA
receptor (MDA5) all lead to an infection-
like disease called Aicardi-Goutie`res syn-
drome (AGS) (Crow, 2013). The common
denominator is that these are all nucleic
acid-catabolizing proteins that participate
in pathways for sensing and/or clearing
away foreign and self-derived nucleic
acids. Presumably, defects in these pro-
teins lead to a build-up of stimulatory
nucleic acids that trick immune cells into
launching a continual antiviral response
characterized by high levels of interferon
(IFN) production and upregulation of
IFN-responsive genes, some of which
encode proteins listed above.In this issue, Stavrou and colleagues
(2015) use murine leukemia virus (MLV)
as an innate immune probe to deduce
how cells detect viral nucleic acids and
implement antiviral programs to limit
infection (Stavrou et al., 2015). MLV is a
distant retroviral relative of the AIDS
viruses HIV-1 and HIV-2. These and other
retroviruses use an enzyme called reverse
transcriptase (RT) to copy their RNA
genome into a double-stranded DNA
that inserts into the host cell genome.
Reverse transcription is an elegant
process that occurs within the relatively
safe confines of the viral capsid, a semi-
permeable lattice that shields the viral
nucleic acid from the harsh milieu of
the cell. Virus replication is thought to
advance almost to completion within the
capsid, and viral DNA is only exposed
to the cytosol for a short time, if at all,
before being inserted into the nuclear
genome. Interestingly, most natural
antiviral mechanisms target the reverse
transcription stage of the retrovirus life-
cycle, including SAMHD1, TRIM5a, andAPOBEC3 DNA cytosine deaminases
(Harris et al., 2012). It is therefore under-
standable that many antiretroviral drugs
also work by blocking this step of the viral
life cycle.
Prior work by the same group had
shown that the MLV capsid is more fragile
in viral variants lacking the amino-terminal
end of the capsid precursor polyprotein
Gag, which harbors several glycosylation
sites (Stavrou et al., 2013). Infection of a
murine macrophage cell line with glyco-
Gag mutant viruses results in elevated
IFN-b production, which skyrockets in
the absence of TREX1, presumably due
to the persistence of more immunostimu-
latory viral DNA replication intermediates.
The replication of glyco-Gag mutant vi-
ruses is strongly restricted by cellular
APOBEC3, as both glyco-Gag mutant
and non-mutant viruses are able to repli-
cate robustly and to similarly high levels
in APOBEC3 null animals. Moreover,
mutations that restore glyco-Gag function
frequently occurred in vivo, but only in
APOBEC3-expressing animals, implyinge 17, April 8, 2015 ª2015 Elsevier Inc. 423
Figure 1. Multidimensional Antiviral Innate Immunity
Cytosolic DNA from a variety of sources, including retrovirus infections, is a
substrate for effector mechanisms such as APOBEC3, TREX1, and other
nucleic acid catabolizing proteins, which collectively serve to eliminate the
offending DNA. If cytosolic DNA persists, it may be sensed by cGAS,
DDX41, and IFI203, and then activation of STING will relay through TBK1
and IRF3 to generate a full-blown interferon response including upregulation
of many effector mechanisms. Self DNA can be from a variety of sources,
including dead cells, as well as from within living cells (e.g., retrotransposon
DNA not shown).
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wild-type Gag is shielding
the virus from APOBEC3-
mediated restriction. To-
gether with biochemical
studies of capsid integrity
with and without the glyco-
sylation region of Gag, a
model emerged in which
glycosylated Gag fortifies
capsid stability.
The present study lever-
ages this unique system to
identify innate immune com-
ponents that recognize viral
DNA (i.e., sensors and/or
sensor transducers), rational-
izing that depleting these crit-
ical components from cells
will block MLV-induced IFN-b production (Stavrou et al., 2015). Four
clear leads were obtained in a series of
knockdown experiments. Depletion of
the recently discovered cytosolic DNA re-
ceptor, cGAS, suppressed IFN-b produc-
tion, as did knockdown of its downstream
signal transducer STING. In this pathway,
cytosolic DNA is bound by cGAS, trig-
gering production of the secondary
messenger cGAMP and activation of
STING, which in turn activates the kinase
TBK1, resulting in phosphorylation and
nuclear translocation of the transcription
factor IRF3 and subsequent induction of
many genes including IFN-b (Barber,
2014; Cai et al., 2014) (Figure 1).
The other two leads had equally strong
effects on MLV-induced IFN-b production
but are harder to integrate in the same
pathway. DDX41 is a DExD/H-box heli-
case previously implicated in responding
to cytosolic DNA (Zhang et al., 2011).
IFI203 has multiple DNA binding domains
and belongs to a larger family of AIM2-
like receptor proteins also implicated
previously in innate immunity to DNA
(Brunette et al., 2012). Interestingly, HIV-
1-based particles also triggered IFN-b
production dependent upon cGAS,
IFI203, and STING, but the requirement
for DDX41 was less stringent. The shared
requirements suggest the existence of
an underlying general mechanism, but
the subtle difference suggests that
different retroviruses may trigger different
innate immune responses. In fact, a series
of co-immunoprecipitation experiments
suggested that IFI203, DDX41, and
STING may be part of the same complex,424 Cell Host & Microbe 17, April 8, 2015 ª2distinct from cGAS (Figure 1). In further
support of this model, cells from IFI203
and STING mutant animals showed
diminished IFN-b production in response
to viral infection.
One of the most interesting, but debat-
able, aspects of the work by Stavrou and
colleagues is the concept of hierarchies in
the DNA sensing and clearing mecha-
nisms. First, the DNA exonuclease
TREX1 is a dominant viral DNA clearing
mechanism, and many of the authors’
observations would not have been
possible had they not first weakened this
defense by depleting TREX1 from cells.
Second, APOBEC3 appears to matter in
both the virus-producing cells and the
soon-to-be-infected target cells. Many
prior studies have shown that APOBEC3
packages into assembling viral particles
in producer cells, yet it exerts its antiviral
effects by deaminating viral cDNA and
blocking reverse transcription in target
cells (likely all within the confines of the
viral capsid). Several reports, including
the predecessor to this study (Stavrou
et al., 2013), have also suggested that
target-cell APOBEC3 may also interfere
with reverse transcription, especially un-
der conditions in which capsid integrity
may be less than perfect (e.g., glyco-
Gag mutants). Thus, APOBEC3may exert
at least two layers of innate immune
protection, and this is evidenced by the
better-than-wild-type infectivity of glyco-
Gag mutant MLV in APOBEC3-deficient
mice in vivo. Moreover, Stavrou and
colleagues show that APOBEC3 even
exerts an antiviral effect in the complete015 Elsevier Inc.absence of STING, suggest-
ing that this could be the first
defense against retroviral in-
fections and perhaps other
types of foreign DNA. The po-
tency of the APOBEC3 de-
fense was further evidenced
by the selection of viral mu-
tants with fully restored
glyco-Gag functionality even
in the absence of STING.
Overall, a model emerges in
which the innate immune
effector proteins APOBEC3
and TREX1 are front-line de-
fenders that can be further
induced if the DNA sensors
are activated by nucleic acids
that escape the front line
(Figure 1).Most aspects of the cytosolic response
to foreign DNA are conserved in
mammals. It is therefore likely that many
of the observations of Stavrou and
colleagues will directly translate to the
human system, and vice versa, as
the field is learning from the ongoing
identification of new AGS genes (Crow,
2013). For instance, given the clear
synergy between APOBEC3 and known
AGS proteins in innate immunity, one of
the human APOBEC3s could easily be
involved in the AGS pathway of nucleic
acid defenses. However, evolution is
a curious beast, and innate immune
proteins often vary in copy number,
amino acid composition, and even func-
tion between species, and therefore
some differences between the different
branches of the mammalian phylogenetic
tree are to be expected. For instance,
most humans have an armada of seven
APOBEC3 proteins, in comparison to
the single enzyme produced in mice,
and partial functional redundancies
may prevent single gene defects from
manifesting as AGS. Nevertheless,
as for the DNA sensors, this partial
redundancy is assuring as it provides
additional security against potentially
harmful foreign nucleic acids, including
retroviral DNA replication intermediates
and many agents of which we are bliss-
fully unaware.ACKNOWLEDGMENTS
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The lentivirus protein Vpx/Vpr recognizes the host restriction factor SAMHD1 at either its N- or C-terminal tail
and targets it for destruction by the cellular protein degradation machinery. In this issue of Cell Host &
Microbe, Schwefel et al. (2015) report the structural basis of SAMHD1 N-terminal targeting by Vpx.Hijacking the host protein degradation
machinery is a common strategy em-
ployed by viruses to target host immune
proteins for destruction. Specifically,
cullin-RING E3 ubiquitin ligases (CRLs)
are frequently exploited by viruses to pol-
yubiquitinate cellular antiviral restriction
factors and target them for degradation
by the proteasome (Barry and Fru¨h,
2006). This type of E3 ubiquitin ligase
machinery contains a cullin scaffolding
protein, substrate receptor proteins that
specify target proteins, and adaptor pro-
teins that bridge the substrate receptor
to the cullin scaffold. Viruses have evolved
proteins that mimic substrate receptors in
order to recruit specific host restriction
factors for degradation. For retroviruses,
including HIV-1, the viral accessory pro-
teins Vif, Vpu, Vpr, and/or Vpx act as sub-
strate receptor mimics (Strebel, 2013).
These viral proteins mediate the degrada-
tion of many extensively studied immune
molecules and retroviral restriction factors
(Figure 1A): Vif targets the viral genome-
mutating enzyme APOBEC3G; Vpu tar-
gets the viral tethering protein BST-2/
Tetherin and the immune molecule CD4;
Vpx or Vpr targets the deoxynucleoside
triphosphate (dNTP)-depleting enzyme
SAMHD1.The Vpx/Vpr-mediated degradation of
SAMHD1 is the most recently discovered
example of viral hijacking of the CRL
ubiquitin-proteasome pathway (Hrecka
et al., 2011; Laguette et al., 2011).
In fact, the knowledge of the interaction
between Vpx and the cullin 4A-DDB1-
DCAF1 ubiquitin ligase predated and
directly led to the discovery of SAMHD1
as the targeted restriction factor.
SAMHD1 inhibits retroviruses, includ-
ing HIV-1, in non-dividing cells such
as myeloid-lineage and resting CD4+
T cells. The dNTP triphosphohydrolase
(dNTPase) activity of the enzyme likely de-
pletes the cellular dNTPs required for viral
reverse transcription. Human SAMHD1
is 626 amino acids long and consists of
an N-terminal tail (residues 1–35), a pro-
tein-interacting sterile alpha motif (SAM)
domain (residues 37–109), a catalytic
histidine-aspartate (HD) domain (residues
110–600), and a C-terminal tail (residues
601–626).
The mechanism by which Vpx/Vpr
targets SAMHD1 is among the most
intriguing of viral CRL-hijacking events
because of the multifaceted targeting
modes employed by Vpx/Vpr (Fregoso
et al., 2013). Vpx proteins of different sim-
ian immunodeficiency virus (SIV) lineagesand HIV-2 recognize either the N or C ter-
minus of SAMHD1 in a species-specific
manner. Vpx from HIV-2 and SIVsmm (SIV
infecting sooty mangabey monkeys) line-
ages target the C-terminal tail of host
SAMHD1, while Vpx from the SIVmnd-2
(infecting mandrill) lineage targets the
N-terminal tail of mandrill SAMHD1. The
Vpx proteins between the two lineages
have 30%–40% sequence identity and
are structurally homologous. Adding to
the complexity, in certain SIV lineages
this recognition is conferred via the Vpx
paralog Vpr. HIV-1 encodes Vpr, but
not Vpx, and does not target SAMHD1
even though HIV-1 Vpr interacts with
the same host E3 ligase (Hrecka et al.,
2007). The target of HIV-1 Vpr is currently
unknown. Analysis of the hijacked host
E3 ligase components shows that
DCAF1, which forms the substrate recep-
tor together with Vpx/Vpr, is virtually
identical across species. Additionally,
human and monkey SAMHD1 are highly
conserved (>93% identical). Perplexing
mechanistic and evolutionary questions
remain, such as how the structurally
homologous Vpx/Vpr proteins use entirely
different SAMHD1 motifs (N- or C-termi-
nal) to recruit SAMDH1 to the same
E3 ligase and how the species-specifice 17, April 8, 2015 ª2015 Elsevier Inc. 425
